Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lobeglitazone vs Pioglitazone as Initial Triple Therapy in Type 2 Diabetes
NCT02315287Phase 4Unknown
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Sep 2014
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lobeglitazone in type 2 diabetes mellitus (T2DM), sponsored by Seoul National University Bundang Hospital. Status: unknown.
02
Drugs
lobeglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02315287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02315287.